Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

Cellonis Biotech Eliminates a Glioma with Stem-Cell-Based Therapy

publication date: Dec 17, 2009
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
Cellonis Biotechnologies of Beijing announced it used a novel technology based on stem cells to eliminate a glioma – brain cancer – in a 36-year-old Norwegian patient. According to the company, the treatment shows an activated immune system can kill tumor stem cells and cancer daughter cells. Cellonis administered the stem-cell-based therapy along with conventional cancer treatments and TCM drugs. More details...



Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...

Login

  

    
   
Alibaba IPO
Event Updates
Greg Scott will be attending and speaking at this event:
 
 
Hope to see you there!
 
ChinaBio® Events
 
China Forum 2014

Frankfurt, Germany
November 2, 2014

>> More events...

Our Partners
Annual Sponsors
Official Partners
Supporting Partners
Media Sponsors